Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 25

Trial Status

Completed4
Recruiting1

Role Distribution

Principal Investigator2
Other Roles3
PI Rate40%

Activity Timeline

Clinical Trials (5)

NCT06305793Phase 2Completed
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Long Coronavirus Disease 2019 (Covid19)Long COVIDLong Covid-19
StudychairStart date: 2024-05-08
NCT06305780Phase 2Completed
RECOVER-AUTONOMIC Platform Protocol
Long COVIDLong Covid-19
StudychairStart date: 2024-03-11
NCT06305806Phase 2Completed
RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
Long COVIDLong Covid-19
StudychairStart date: 2024-03-11
NCT03012386Phase 1/2Completed
CD36 in Nutrient Delivery and Its Dysfunction
Endothelial DysfunctionInsulin Resistance
PrincipalinvestigatorStart date: 2017-01-01

Research Network

Collaboration Network

9 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Peter Novak, MD

Harvard

Moderately Similar
3 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 3 trials
Similarity Score42%

Tae Chung, MD

Johns Hopkins University

Moderately Similar
3 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 3 trials
Similarity Score42%

Pam Taub, MD

University of California, San Diego

Moderately Similar
5 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 3 trials
Similarity Score42%

Christopher Grainger, MD

Duke Clinical Research Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Post-Acute COVID-19 SyndromeLong Covid-19Long Coronavirus Disease 2019 (Covid19)

Worked with same sponsors:

Kanecia Obie Zimmerman
Collaborated on 2 trials
Similarity Score38%

David Putrino, PT, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Long Covid-19Post-Acute COVID-19 Syndrome
Similarity Score12%

Cara B Ebbeling, PhD

Boston Children's Hospital

Related
10 trials

Shared therapeutic areas:

Insulin Resistance
Similarity Score6%

Eric Lenze, MD

Washington University School of Medicine

Related
10 trials

Shared therapeutic areas:

Post-Acute COVID-19 Syndrome

Worked with same sponsors:

Washington University School of Medicine
Similarity Score6%

Santiago Navas-Carretero, PhD

University of Navarra

Related
5 trials

Shared therapeutic areas:

Insulin Resistance
Similarity Score6%

Yasser Yehia El-Sayed

Stanford University

Related
9 trials

Shared therapeutic areas:

Insulin Resistance
Similarity Score6%

Penny M Kris-Etherton, PhD

Penn State University

Related
13 trials

Shared therapeutic areas:

Insulin Resistance
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06305793Phase 2StudyChair

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Long Coronavirus Disease 2019 (Covid19)Long COVIDLong Covid-19
Completed
NCT06305780Phase 2StudyChair

RECOVER-AUTONOMIC Platform Protocol

Long COVIDLong Covid-19
Completed
NCT06305806Phase 2StudyChair

RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

Long COVIDLong Covid-19
Completed
NCT04769206Phase 1/2PrincipalInvestigator

Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans

Endothelial Dysfunction
Recruiting
NCT03012386Phase 1/2PrincipalInvestigator

CD36 in Nutrient Delivery and Its Dysfunction

Endothelial DysfunctionInsulin Resistance
Completed

All 5 trials loaded